Atlas Arteria (ASX:ALX) - Cours de l'action, nouvelles et analyse

ALX Aperçu des actions

Atlas Arteria Limited possède, développe et exploite des routes à péage. Plus de détails

ALX analyse fondamentale
Score flocon de neige
Évaluation	3/6
Croissance future	4/6
Performances passées	2/6
Santé financière	3/6
Dividendes	4/6

Récompenses

Se négocie à 49.4% en dessous de notre estimation de sa juste valeur

Les bénéfices devraient augmenter 21.84% par an

Analyse des risques

Le dividende de 8.4% n'est pas bien couvert par les bénéfices ou les flux de trésorerie disponibles

Atlas Arteria Limited Concurrents

Transurban Group

ASX:TCL

AU$39.0b

Qube Holdings

ASX:QUB

AU$6.9b

Aurizon Holdings

ASX:AZJ

AU$6.1b

Dalrymple Bay Infrastructure

ASX:DBI

AU$1.7b

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Atlas Arteria
Historique des cours de bourse
Prix actuel de l'action	AU$4.76
Plus haut sur 52 semaines	AU$5.88
Plus bas sur 52 semaines	AU$4.63
Bêta	0.76
1Variation sur 1 mois	-4.80%
Variation sur 3 mois	-6.67%
Variation sur 1 an	-17.36%
3Variation sur 3 ans	-30.61%
Variation sur 5 ans	-38.18%
Évolution depuis l'introduction en bourse	673.98%

Nouvelles et mises à jour récentes

Recent updates

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Apr 07

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Dec 22

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Aug 10

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

May 31

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Apr 14

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Mar 03

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Feb 27

Atlas Arteria (ASX:ALX) Has Compensated Shareholders With A Respectable 78% Return On Their Investment

Jan 31

Atlas Arteria Limited (ASX:ALX) Shares Could Be 44% Below Their Intrinsic Value Estimate

Dec 27

How Many Atlas Arteria Limited (ASX:ALX) Shares Do Institutions Own?

Dec 06

Is There Now An Opportunity In Atlas Arteria Limited (ASX:ALX)?

Nov 19

Atlas Arteria (ASX:ALX) Has Gifted Shareholders With A Fantastic 142% Total Return On Their Investment

Jul 30

Rendement pour les actionnaires

	ALX	AU Infrastructure	AU Marché
7D	-0.6%	0.6%	1.5%
1Y	-17.4%	-0.7%	17.2%

Rendement vs Industrie: ALX a sous-performé le secteur Australian Infrastructure qui a rapporté -0.7 % au cours de l'année écoulée.

Rendement vs marché: ALX a sous-performé le marché Australian qui a rapporté 17.2 % au cours de l'année écoulée.

Volatilité des prix

Is ALX's price volatile compared to industry and market?
ALX volatility
ALX Average Weekly Movement	3.1%
Infrastructure Industry Average Movement	2.6%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

Cours de l'action stable: ALX n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de ALX ( 3% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
2009	n/a	Hugh Wehby	www.atlasarteria.com

Atlas Arteria Limited possède, développe et exploite des routes à péage. Elle détient une participation de 31,14 % dans l'APRR et l'A79 et de 31,17 % dans l'ADELAC situées en France ; une participation de 100 % dans le tunnel Warnow situé à Rostock, en Allemagne ; une participation de 66,67 % dans le Chicago Skyway situé à Chicago et une participation de 100 % dans le Dulles Greenway situé en Virginie, aux États-Unis. La société était auparavant connue sous le nom de Macquarie Atlas Roads Limited et a changé de nom pour devenir Atlas Arteria Limited en mai 2018.

Atlas Arteria Limited Résumé des fondamentaux

Comment les bénéfices et les revenus de Atlas Arteria se comparent-ils à sa capitalisation boursière ?
ALX statistiques fondamentales
Capitalisation boursière	AU$6.91b
Bénéfices(TTM)	AU$300.20m
Recettes(TTM)	AU$140.10m

23.0x

Ratio P/E

49.3x

Ratio P/S

Le site ALX est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
ALX compte de résultat (TTM)
Recettes	AU$140.10m
Coût des recettes	AU$47.80m
Marge brute	AU$92.30m
Autres dépenses	-AU$207.90m
Les revenus	AU$300.20m

Derniers bénéfices déclarés

Jun 30, 2024

Prochaine date de publication des résultats

Feb 26, 2025

Résultat par action (EPS)	0.21
Marge brute	65.88%
Marge bénéficiaire nette	214.28%
Ratio dettes/capitaux propres	27.2%

Quelles ont été les performances à long terme de ALX?

Voir les performances historiques et les comparaisons

Dividendes

8.4%

Rendement actuel des dividendes

194%

Ratio de distribution

ALX Aperçu des actions

Récompenses

Analyse des risques

Atlas Arteria Limited Concurrents

ASX:TCL

AU$39.0b

ASX:QUB

AU$6.9b

ASX:AZJ

AU$6.1b

ASX:DBI

AU$1.7b

Historique des prix et performances

Nouvelles et mises à jour récentes

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Recent updates

First half dividend of AU$0.20 announced

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2024, Payable on 7 October 2024

High number of new directors

Consensus revenue estimates fall by 13%

First half 2024 earnings: EPS and revenues miss analyst expectations

Now 20% undervalued after recent price drop

Atlas Arteria Limited Appoints Hugh Wehby as Managing Director

Atlas Arteria Limited to Report First Half, 2025 Results on Aug 28, 2025

Final dividend of AU$0.20 announced

Atlas Arteria Limited Announces the Retirement of Graeme Bevans as CEO and Managing Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 31 December 2023, Payable on 8 April 2024

Atlas Arteria Limited, Annual General Meeting, May 15, 2024

Atlas Arteria Limited, Annual General Meeting, May 16, 2024

Full year 2023 earnings released: EPS: AU$0.22 (vs AU$0.25 in FY 2022)

Atlas Arteria Appoints Laura Hendricks to the Board as an Independent Non-Executive Director

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Estimated Payment Date Is 5 October 2023

Atlas Arteria Limited Announces Distribution for the Six Months Ended 30 June 2023, Payable on 5 October 2023

Consensus EPS estimates fall by 11%

First half 2023 earnings released: EPS: AU$0.12 (vs AU$0.13 in 1H 2022)

Atlas Arteria Limited Reaffirms Distribution Guidance for the First Half and Second Half of 2023

Atlas Arteria Limited to Report First Half, 2024 Results on Aug 29, 2024

Atlas Arteria Limited Appoints Ken Daley as Director

Atlas Arteria Limited Announces Caroline Foulger Will Retire as A Director, with Effect from 1 July 2023

Consensus EPS estimates fall by 15%

Full year 2022 earnings released: EPS: AU$0.25 (vs AU$0.19 in FY 2021)

Insufficient new directors

Atlas Arteria Limited Announces Board Changes

Atlas Arteria Limited (ASX:ALX) completed the acquisition of 66.67% stake in Skyway Concession Company, LLC from CPP Investments and OMERS Infrastructure.

Now 20% undervalued after recent price drop

Atlas Arteria Limited, Annual General Meeting, Apr 27, 2023

Consensus revenue estimates increase by 10%

Atlas Arteria Limited to Report Q4, 2022 Results on Feb 23, 2023

Price target decreased to AU$6.96

Investor sentiment deteriorated over the past week

Atlas Arteria Limited Provides Distribution Guidance for the Year 2023

Atlas Arteria Limited (ASX:ALX) entered into an agreement to acquire a 66.67% stake in Skyway Concession Company, LLC for $2 billion.

Consensus EPS estimates fall by 14%

First half 2022 earnings released: EPS: AU$0 (vs AU$0.074 in 1H 2021)

Atlas Arteria Limited Provides Dividend Guidance for the First Half of 2022

Price target increased to AU$7.40

Investor sentiment improved over the past week

Atlas Arteria Limited Announces Executive Changes

Is Now An Opportune Moment To Examine Atlas Arteria Limited (ASX:ALX)?

Independent Non-Executive Director recently bought AU$76k worth of stock

Full year 2021 earnings: EPS and revenues miss analyst expectations

What Does Atlas Arteria Limited's (ASX:ALX) Share Price Indicate?

Insider recently bought AU$67k worth of stock

First half 2021 earnings released: EPS AU$0.074 (vs AU$0.14 loss in 1H 2020)

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 43% Undervaluation?

Is Atlas Arteria (ASX:ALX) Using Too Much Debt?

Price target decreased to AU$6.21

Is There An Opportunity With Atlas Arteria Limited's (ASX:ALX) 48% Undervaluation?

Debra Goodin Is The Independent Chairman of the Board of Atlas Arteria Limited (ASX:ALX) And They Just Picked Up 54% More Shares

Independent Chairman of the Board recently bought AU$100k worth of stock

Here's Why Atlas Arteria (ASX:ALX) Can Afford Some Debt

Full year 2020 earnings released: AU$0.061 loss per share (vs AU$0.024 profit in FY 2019)

Atlas Arteria Limited Announces Board Changes

New 90-day low: AU$5.97

Atlas Arteria Limited to Report Fiscal Year 2020 Results on Feb 25, 2021